Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sleep Apnea, Coronary Atherosclerosis and Heart Failure in Diabetes Patients With Nephropathy

NCT04549324 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.

NCT NCT04549324
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04549324 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sleep Apnea, Coronary Atherosclerosis and Heart Failure in Diabetes Patients With Nephropathy
Lead sponsor
University of Aarhus
Phase
Observational
Overall status
Completed
Start date
October 1, 2020
Completion date
January 24, 2022
Enrollment
74 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arterial stiffness, coronary atheroscleroses, diabetic nephropathy type 2, heart insufficiency, kidney diseases, sleep apnea, vascular diseases